A Randomized Controlled Study to Assess the Effects of Bisoprolol and Atenolol on Resting Heart Rate and Sympathetic Nervous System's Activity in Subjects With Essential Hypertension
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 177 participants.
Also called NCT01251146
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 177 participants
- Registry
-
NCT01251146
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01251146. Randomized; no masking; primary purpose treatment. Start 2010-11 (registry gives no type); primary completion 2012-02 (actual). Results posted on 2012-11-30.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Randomized Controlled Study to Assess the Effects of Bisoprolol and Atenolol on Resting Heart Rate and Sympathetic Nervous System's Activity in Subjects With Essential Hypertension
- Condition
- Hypertension
- Intervention (Drug)
- Bisoprolol
- Intervention (Drug)
- Atenolol
- Lead sponsor
- Merck KGaA, Darmstadt, Germany
- Collaborator
- Merck Serono Co., Ltd., China
Record details
- Record id
cardio:ct-nct01251146- Content hash
5da8f606731d792ba3cb11b593bef82fd8b4209cd8d7710df784831cfc862f9e